NEVVI Medicare utilization intelligence
or

← back

Provider profile

MAKHLOUF, GRACE M.D.

Rheumatology · NPI 1124073655 · SUGAR LAND, TX

1
Groups
23
Codes · 2024
176,351
Disclosed services

MAKHLOUF, GRACE is a Rheumatology in SUGAR LAND, TX, a member of 1 medical group, who billed 23 distinct codes to Medicare Part B in 2024.

Groups: HILLCROFT MEDICAL CLINIC ASSOC (SUGAR LAND, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

176,351
disclosed services
23
codes billed to Medicare Part B
Prior year · CY2023 206,422 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1602 Injection, golimumab, 1 mg, for intravenous use
J1745 Injection, infliximab, excludes biosimilar, 10 mg
96413 Administration of chemotherapy into vein, 1 hour or less
36415 Insertion of needle into vein for collection of blood sample
85652 Red blood cell sedimentation rate, to detect inflammation, automated
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
86140 Measurement c-reactive protein for detection of infection or inflammation
82565 Blood creatinine level
80076 Liver function blood test panel
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
82728 Ferritin (blood protein) level
83540 Iron level
84466 Transferrin (iron binding protein) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G0008 Administration of influenza virus vaccine
90662 Influenza vaccine split virus, preservative free
77085 Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.